DIStal gastriC Bypass OUtcome in Revision SurgEry After Roux-en-y Gastric Bypass
DISCOURSE
1 other identifier
interventional
150
1 country
8
Brief Summary
This study is designed as a prospective multicenter randomized controlled clinical trial comparing two surgical techniques of distal gastric bypass (DGB) in revisional surgery following failed Roux-en-Y gastric bypass. Patients will be randomly allocated 1:1 to A) DGB with lengthening of the BPL (DGB type I) or B) DGB with extended AL (DGB type II). Randomisation is stratified for participating center. The study will be performed in a clinical and out-patient setting with regular visits at 1.5, 3, 6, 12, 18, 24 and 36 months post intervention. The study will be set up as a multicenter study with bariatric centers: St. Antonius hospital, Groene Hart hospital, OLVG, Rijnstate hospital, Elisabeth Twee-steden Hospital, Bravis hospital, Medisch Centrum Leeuwarden, Catharina Hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2021
Longer than P75 for not_applicable
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 13, 2021
CompletedStudy Start
First participant enrolled
May 1, 2021
CompletedFirst Posted
Study publicly available on registry
May 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2029
April 27, 2026
April 1, 2026
8.3 years
April 13, 2021
April 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Weight loss
Percentage total weight loss (%TWL) 1 year after treatment
1 year post-operative
Number of Participants with development of protein calorie malnutrition (PCM)
\>6 times/day defecation patterns with diarrhea, assessed by fecal score questionnaire
1 year postoperative
Secondary Outcomes (9)
Weight loss
Up to 3 year follow up
TWL
3, 6, 12, 18, 24, 36 month follow up
Defecation pattern
3, 12 and 36 months postoperative
PCM grading
up to 3 year follow up
Complications
uo to 3 year follow up
- +4 more secondary outcomes
Study Arms (2)
Distal gastric bypass type I
EXPERIMENTALLaparoscopic distalisation of RYGB type I. The RYGB is modified by dividing the Roux limb (AL) at the jejuno-jejunal anastomosis and re-anastomosed distally to 200 cm from the ileocecal valve using linear staplers, creating a long biliopancreatic limb (BPL). In cases of initial AL lengths shorter than 100 cm, the CC lengths should be adjusted to create a TALL of at least 300 cm.
Distal gastric bypass type II
EXPERIMENTALLaparoscopic distalisation of RYGB type II. The RYGB is modified by dividing the BPL at the jejuno-jejunal anastomosis and re-anastomosed distally to 200 cm from the ileocecal valve using linear staplers, creating a long AL.
Interventions
Distal gastric bypass, revisonal surgery after failed RYGB
Eligibility Criteria
You may qualify if:
- Age 18-65 years;
- BMI ≥40 kg/m2 or BMI ≥35 kg/m2 with obesity related comorbidity;
- Weight regain or insufficient weight loss (EWL\<50% or TWL\<20%)15,16 following RYGB;
- Multidisciplinary team screening at one of the bariatric centres;
- Informed consent and willing to enter the follow-up program.
You may not qualify if:
- Failed Roux-en-Y gastric bypass due to anatomic, surgical reasons (gastric pouch dilatation \>50 mL, gastro-gastric fistula, gastro-jejunostomy);
- Distalisation of RYGB is technical infeasible (judgment by surgeon);
- Inflammatory bowel disease, celiac disease, irritable bowel syndrome and other causes of chronic diarrhea;
- Severe concomitant disease (such as carcinomas and neurodegenerative disorders);
- Pregnant women;
- Noncompliance in follow-up or unwilling to undergo surgery;
- Inability of reading/understanding and filling out questionnaires.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- St. Antonius Hospitallead
- Medtroniccollaborator
Study Sites (8)
Rijnstate Hospital
Arnhem, Gelderland, 6815 AD, Netherlands
Catharina Ziekenhuis
Eindhoven, North Brabant, 5623 EJ, Netherlands
Bravis Hospital
Roosendaal, North Brabant, 4708 AE, Netherlands
Elisabeth-Tweesteden Hospital
Tilburg, North Brabant, 5022 GC, Netherlands
OLVG
Amsterdam, North Holland, 1061 AE, Netherlands
Medisch Centrum Leeuwarden
Leeuwarden, Provincie Friesland, 8934 AD, Netherlands
Groene Hart Hospital
Gouda, South Holland, 2803 HH, Netherlands
St. Antonius hospital
Nieuwegein, Utrecht, 3435 CM, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
M.J. Wiezer, PhD, MD
St. Antonius Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Patients who meet the eligibility criteria will be included in this trial at the outpatient clinic of the participating bariatric centres after informed consent is obtained. The participating patients will be randomised into one of the surgical techniques: type I or type II DGB. Randomisation will take place in the operating room through an internet-based randomisation system in REDCap. Only the participants are blinded to the treatment allocation. The randomisation table will be created by an independent epidemiologist in the St. Antonius hospital, ensuring concealment of treatment allocation. Participants will be randomised in equal numbers to both interventions. The randomisation will be stratified by participating hospitals to ensure participants are evenly allocated to each treatment arm at each participation hospital.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. M.J. Wiezer
Study Record Dates
First Submitted
April 13, 2021
First Posted
May 20, 2021
Study Start
May 1, 2021
Primary Completion (Estimated)
September 1, 2029
Study Completion (Estimated)
December 1, 2029
Last Updated
April 27, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share